{
    "code": "10000819",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=10000819",
    "time": "2015-12-18 05:52:32",
    "許可證字號": "衛署菌疫輸字第000819號",
    "註銷狀態": "已註銷",
    "註銷日期": "103\/08\/01",
    "註銷理由": "自請註銷",
    "有效日期": "104\/11\/10",
    "發證日期": "94\/11\/10",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA01000081900",
    "中文品名": "爾必得舒注射液",
    "英文品名": "ERBITUX",
    "適應症": "Erbitux與FOLFIRI(Folinic acid\/5-FU\/Irinotecan)合併使用於治療具表皮生長因子受體表現型(EGFR expressing)，KRAS原生型(wild-type)之轉移性直腸結腸癌病患之第一線治療。Erbitux與放射線療法合併使用，治療局部晚期之口咽癌、下咽癌及喉癌患者。Erbitux與內含platinum類之化學療法合併使用，治療復發及\/或轉移性頭頸部鱗狀細胞癌患者。",
    "劑型": "270注射劑",
    "包裝": "50毫升瓶裝",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "CETUXIMAB, CHIMERIC ANTIBODY",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1419601100  臺灣默克股份有限公司",
    "申請商地址": "台北市內湖區堤頂大道2段89號6樓",
    "主製造廠": {
        "製造廠名稱": "F470215200  BOEHRINGER INGELHEIM PHARMA GMBH &amp; CO. KG",
        "製造廠廠址": "BIRKENDORFER STRASSE 65, 88397 BIBERACH AN DER RISS, GERMANY",
        "製造廠公司地址": "",
        "製造廠國別": "GERMANY",
        "製程": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "F470021200  BOEHRINGER INGELHEIM Pharma GmbH &amp; Co.KG",
            "製造廠廠址": "BIRKENDORFER STRASSE 65, 88397 BIBERACH AN DER RISS.  GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": "主成分(drug substance)製造廠"
        },
        {
            "製造廠名稱": "F470076000  MERCK KGaA",
            "製造廠廠址": "FRANKFURTER STRASSE 250, 64293 DARMSTADT\/GERMANY、POSTFACH：64271 DARMSTADT\/GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": "包裝與持有許可證"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013000900",
            "成分名稱": "CETUXIMAB, CHIMERIC ANTIBODY",
            "含量描述": "",
            "含量": "2.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Erbitux 2mg 英文仿單-修F___20120507.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000819&Seq=005&Type=9"
        },
        {
            "title": "Erbitux 2mg 中文仿單-修F___20120507.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000819&Seq=004&Type=9"
        },
        {
            "title": "100008190002___20110623.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000819&Seq=003&Type=9"
        },
        {
            "title": "100008190001___20110623.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000819&Seq=002&Type=9"
        },
        {
            "title": "100008190001___20110106.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000819&Seq=001&Type=9"
        },
        {
            "title": "100008190002___20110106.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000819&Seq=002&Type=8"
        },
        {
            "title": "100008190001___20110106.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000819&Seq=001&Type=8"
        }
    ]
}